Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL HEALTHCARE CHATBOTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL HEALTHCARE CHATBOTS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.11 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL HEALTHCARE CHATBOTS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL HEALTHCARE CHATBOTS MARKET, BY COMPONENT
6.1 OVERVIEW
6.2 SOFTWARE
6.3 SERVICES
6.3.1 DEVELOPMENT SERVICES
6.3.2 INTEGRATION SERVICES
6.3.3 SUPPORT SERVICES
7 GLOBAL HEALTHCARE CHATBOTS MARKET, BY TYPE
7.1 OVERVIEW
7.2 SCRIPTED CHATBOX
7.3 CONTEXTUAL CHATBOX
7.4 MESSAGING CHATBOX
7.5 OTHERS
8 GLOBAL HEALTHCARE CHATBOTS MARKET, BY DEPLOYMENT MODEL
8.1 OVERVIEW
8.2 ON-PREMISE MODEL
8.3 CLOUD-BASED MODEL
8.4 WEB BASED
9 GLOBAL HEALTHCARE CHATBOTS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 SYMPTOIM ASSESSMENT
9.3 APPOINTMENT SCHEDULING & MEDICAL GUIDANCE
9.4 MEDICATION ASSISTANCE
9.5 MARKETING AND SALES
9.6 PATIENT ENGAGEMENT
9.7 COVERAGE AND CLAIMS MANAGEMENT
9.8 PERSONAL HEALH ADVISOR CHATBOT
9.9 MEDICAL REMINDER
9.1 PROVIDE MENTAL HEALTH ASSISTANCE
9.11 OTHERS
10 GLOBAL HEALTHCARE CHATBOTS MARKET, BY END USER
10.1 OVERVIEW
10.2 HEALTHCARE PROVIDER
10.3 HEALTHCARE PAYER
10.4 PATIENTS
10.5 OTHERS
11 GLOBAL HEALTHCARE CHATBOTS MARKET, BY REGION
11.1 GLOBAL HEALTHCARE CHATBOTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 U.K.
11.3.4 FINLAND
11.3.5 DENMARK
11.3.6 NORWAY
11.3.7 POLAND
11.3.8 ITALY
11.3.9 SPAIN
11.3.10 RUSSIA
11.3.11 TURKEY
11.3.12 BELGIUM
11.3.13 NETHERLANDS
11.3.14 SWITZERLAND
11.3.15 SWEDEN
11.3.16 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 SOUTH KOREA
11.4.4 INDIA
11.4.5 SINGAPORE
11.4.6 THAILAND
11.4.7 INDONESIA
11.4.8 MALAYSIA
11.4.9 PHILIPPINES
11.4.10 AUSTRALIA
11.4.11 NEW ZEALAND
11.4.12 VIETNAM
11.4.13 TAIWAN
11.4.14 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 SAUDI ARABIA
11.6.3 UAE
11.6.4 EGYPT
11.6.5 KUWAIT
11.6.6 OMAN
11.6.7 ISRAEL
11.6.8 BAHRAIN
11.6.9 REST OF MIDDLE EAST AND AFRICA
11.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 GLOBAL HEALTHCARE CHATBOTS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12.5 MERGERS & ACQUISITIONS
12.6 EXPANSIONS
12.7 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
13 GLOBAL HEALTHCARE CHATBOTS MARKET, SWOT AND DBMR ANALYSIS
14 GLOBAL HEALTHCARE CHATBOTS MARKET, COMPANY PROFILE
14.1 GYANT.COM, INC.
14.1.1 COMPANY OVERVIEW
14.1.2 GEOGRAPHIC PRESENCE
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 NUANCE COMMUNICATIONS, INC.
14.2.1 COMPANY OVERVIEW
14.2.2 REVENUE ANALYSIS
14.2.3 GEOGRAPHIC PRESENCE
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 EGAIN
14.3.1 COMPANY OVERVIEW
14.3.2 REVENUE ANALYSIS
14.3.3 GEOGRAPHIC PRESENCE
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPEMENTS
14.4 INBENTA TECHNOLOGIES INC.
14.4.1 COMPANY OVERVIEW
14.4.2 GEOGRAPHIC PRESENCE
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPEMENTS
14.5 ECREATIONS
14.5.1 COMPANY OVERVIEW
14.5.2 GEOGRAPHIC PRESENCE
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPEMENTS
14.6 CX COMPANY
14.6.1 COMPANY OVERVIEW
14.6.2 GEOGRAPHIC PRESENCE
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPEMENTS
14.7 NEXT IT CORP. (A SUBSIDIARY OF VERINT)
14.7.1 COMPANY OVERVIEW
14.7.2 REVENUE ANALYSIS
14.7.3 GEOGRAPHIC PRESENCE
14.7.4 PRODUCT PORTFOLIO
14.7.5 RECENT DEVELOPEMENTS
14.8 SYNTHETIX LTD.
14.8.1 COMPANY OVERVIEW
14.8.2 GEOGRAPHIC PRESENCE
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPEMENTS
14.9 YOUR.MD
14.9.1 COMPANY OVERVIEW
14.9.2 GEOGRAPHIC PRESENCE
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPEMENTS
14.1 CREATIVE VIRTUAL
14.10.1 COMPANY OVERVIEW
14.10.2 GEOGRAPHIC PRESENCE
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPEMENTS
14.11 GYANT.COM, INC
14.11.1 COMPANY OVERVIEW
14.11.2 GEOGRAPHIC PRESENCE
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPEMENTS
14.12 WOEBOT
14.12.1 COMPANY OVERVIEW
14.12.2 GEOGRAPHIC PRESENCE
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPEMENTS
14.13 PACT CARE BV
14.13.1 COMPANY OVERVIEW
14.13.2 GEOGRAPHIC PRESENCE
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPEMENTS
14.14 ADA HEALTH GMBH
14.14.1 COMPANY OVERVIEW
14.14.2 GEOGRAPHIC PRESENCE
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPEMENTS
14.15 ANBOTO
14.15.1 COMPANY OVERVIEW
14.15.2 GEOGRAPHIC PRESENCE
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPEMENTS
14.16 SENSELY, INC.
14.16.1 COMPANY OVERVIEW
14.16.2 GEOGRAPHIC PRESENCE
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPEMENTS
14.17 BUOY HEALTH, INC.
14.17.1 COMPANY OVERVIEW
14.17.2 GEOGRAPHIC PRESENCE
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPEMENTS
14.18 INFERMEDICA
14.18.1 COMPANY OVERVIEW
14.18.2 GEOGRAPHIC PRESENCE
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPEMENTS
14.19 BABYLON
14.19.1 COMPANY OVERVIEW
14.19.2 GEOGRAPHIC PRESENCE
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPEMENTS
14.2 BAIDU, INC.
14.20.1 COMPANY OVERVIEW
14.20.2 REVENUE ANALYSIS
14.20.3 GEOGRAPHIC PRESENCE
14.20.4 PRODUCT PORTFOLIO
14.20.5 RECENT DEVELOPEMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
15 RELATED REPORTS
16 QUESTIONNAIRE
17 ABOUT DATA BRIDGE MARKET RESEARCH
